Skip to main content
NCBI home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 Mar 15;10(1):157–165. doi: 10.1111/j.1582-4934.2006.tb00297.x

N-Acetyl-L-Cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-β signalling

Jürgen Kopp a,*, Harun Seyhan a, Bastian Müller a, Johanna Lanczak a, Elke Pausch a, Axel M Gressner b, Steven Dooley c, Raymund E Horch a
PMCID: PMC3933108  PMID: 16563228

Abstract

Dupuytren's disease, a benign fibroproliferative disorder of the palmar fascia, represents an ideal model to study tissue fibrosis. Transforming growth factor-β1 (TGF-β1) and its downstream Smad signalling system is well established as a key player during fibrogenesis. Thus, targeting this basic pathomechanism seems suitable to establish new treatment strategies. One such promising treatment involves the substance N-acetyl-L-cysteine (NAC), shown to have antifibrotic properties in hepatic stellate cells and rat fibroblasts. In order to investigate antifibrotic effects of N-acetyl-L-cysteine (NAC), fibroblasts were isolated from surgically resected fibrotic palmar tissues (Dupuytren fibroblasts, DF) and exposed to different concentrations of NAC and recombinant TGF-β1. Fibroblasts isolated from tendon pulleys served as controls (control fibroblasts, CF). Smad signalling was investigated by a Smad binding element driven reporter gene analysis. Both cell types express TGF-β1, indicating autocrine signalling in DF and CF. This was confirmed by comparing reporter gene activity from LacZ and Smad7 adenovirus infected cells. NAC treatment resulted in abrogation of Smad mediated signalling comparable to ectopically overexpressed Smad7, even when the cells were stimulated with recombinant TGF-β1 or ectopically expressed a constitutively active TGF-β receptor type I. Additionally, NAC dose-dependently decreased expression of three major indicators of impaired fibrotic matrix turnover, namely alpha-smooth muscle actin (α-SMA), α 1 type I procollagen (CollA1), and plasminogen activator inhibitor-type I (PAI-1). Our results suggest that TGF-β signalling and subsequent expression of fibrogenesis related proteins in Dupuytren's disease is abrogated by NAC thus providing a basis for a therapeutic strategy in Dupuytren's disease and other fibroproliferative disorders.

Keywords: signal transduction, fibrogenesis, adenoviral gene transfer, Dupuytren's disease

References

  • 1.McFarlane RM. On the origin and spread of Dupuytren's disease. J Hand Surg [Am] 2002;27:385–90. doi: 10.1053/jhsu.2002.32334. [DOI] [PubMed] [Google Scholar]
  • 2.Bradlow A, Mowat AG. Dupuytren's contracture and alcohol. Ann Rheum Dis. 1986;45:304–7. doi: 10.1136/ard.45.4.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.An HS, Southworth SR, Jackson WT, Russ B. Cigarette smoking and Dupuytren's contracture of the hand. J Hand Surg [Am] 1988;13:872–4. doi: 10.1016/0363-5023(88)90262-6. [DOI] [PubMed] [Google Scholar]
  • 4.Ross DC. Epidemiology of Dupuytren's disease. Hand Clin. 1999;15:53–62. , vi. [PubMed] [Google Scholar]
  • 5.Hueston JT. Dupuytren's contracture and specific injury. Med J Aust. 1968;1:1084–5. doi: 10.5694/j.1326-5377.1968.tb29329.x. [DOI] [PubMed] [Google Scholar]
  • 6.Burge P. Genetics of Dupuytren's disease. Hand Clin. 1999;15:63–71. [PubMed] [Google Scholar]
  • 7.Meek RM, McLellan S, Crossan JF. Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids. J Bone Joint Surg Br. 1999;81:732–8. doi: 10.1302/0301-620x.81b4.9163. [DOI] [PubMed] [Google Scholar]
  • 8.Hasselbacher K, Bleuel S, Landsleitner Dagger B. [Long-term results of the palmar arthrolysis of the proximal interphalangeal joint] Handchir Mikrochir Plast Chir. 2002;34:355–62. doi: 10.1055/s-2002-37473. [DOI] [PubMed] [Google Scholar]
  • 9.Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg [Am] 2000;25:291–6. doi: 10.1053/jhsu.2000.jhsu25a0291. [DOI] [PubMed] [Google Scholar]
  • 10.Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of α-smooth muscle actin and the response to stimulation by TGF-β1. J Hand Surg [Br] 2003;28:351–6. doi: 10.1016/s0266-7681(03)00135-9. [DOI] [PubMed] [Google Scholar]
  • 11.Meurer SK, Lahme B, Tihaa L, Weiskirchen R, Gressner AM. N-acetyl-L-cysteine suppresses TGF-β signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol. 2005;70:1026–34. doi: 10.1016/j.bcp.2005.07.001. [DOI] [PubMed] [Google Scholar]
  • 12.Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640–52. doi: 10.1152/ajpcell.1998.275.6.C1640. [DOI] [PubMed] [Google Scholar]
  • 13.Tubiana R, Michon J, Thomine JM. Scheme for the assessment of deformities in Dupuytren's disease. Surg Clin North Am. 1968;48:979–84. doi: 10.1016/s0039-6109(16)38630-3. [DOI] [PubMed] [Google Scholar]
  • 14.Gay RE, Buckingham RB, Prince RK, Gay S, Rodnan GP, Miller EJ. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis. Arthritis Rheum. 1980;23:190–6. doi: 10.1002/art.1780230209. [DOI] [PubMed] [Google Scholar]
  • 15.Dooley S, de Lvoux B, Streckert M, Bonzel L, Stopa M, van Dijke P, Gressner AM. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFβ signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001;502:4–10. doi: 10.1016/s0014-5793(01)02656-4. [DOI] [PubMed] [Google Scholar]
  • 16.Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawabata M, Kato M, Ichijo H, Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell. 1999;10:3801–13. doi: 10.1091/mbc.10.11.3801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.de Nnler S, Itoh S, Vivien D, van Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17:3091–100. doi: 10.1093/emboj/17.11.3091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Berg F, de Lvoux B, Gao CF, Westhoff JH, Breitkopf K, Gressner AM, Dooley S. Divergence of TGFβ signaling in activated hepatic stellate cells downstream from Smad2 phosphorylation. Signal Transduction. 2002;1:1–18. [Google Scholar]
  • 19.Ammann AJ, Beck LS, de Guzman L, Hirabayashi SE, Lee WP, McFatridge L, Nguyen T, Xu Y, Mustoe TA. Transforming growth factor-β. Effect on soft tissue repair. Ann N Y Acad Sci. 1990;593:124–34. doi: 10.1111/j.1749-6632.1990.tb16105.x. [DOI] [PubMed] [Google Scholar]
  • 20.Bains W. Vasoprotective VEGF as a candidate for prevention of recurrence of fibrotic diseases such as Dupuytren's contracture. Med Hypotheses. 2003;60:793–6. doi: 10.1016/s0306-9877(02)00397-3. [DOI] [PubMed] [Google Scholar]
  • 21.Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K. The role of transforming growth factor β in Dupuytren's disease. J Hand Surg [Am] 1996;21:210–5. doi: 10.1016/S0363-5023(96)80102-X. [DOI] [PubMed] [Google Scholar]
  • 22.Badalamente MA, Stern L, Hurst LC. The pathogenesis of Dupuytren's contracture: contractile mechanisms of the myofibroblasts. J Hand Surg [Am] 1983;8:235–43. doi: 10.1016/s0363-5023(83)80150-6. [DOI] [PubMed] [Google Scholar]
  • 23.Badalamente MA, Hurst LC. The biochemistry of Dupuytren's disease. Hand Clin. 1999;15:35–42. , v-vi. [PubMed] [Google Scholar]
  • 24.Hindman HB, Marty-Roix R, Tang JB, Jupiter JB, Simmons BP, Spector M. Regulation of expression of α-smooth muscle actin in cells of Dupuytren's contracture. J Bone Joint Surg Br. 2003;85:448–55. doi: 10.1302/0301-620x.85b3.13219. [DOI] [PubMed] [Google Scholar]
  • 25.Bazin S, Le Lous M, Duance VC, Sims TJ, Bailey AJ, Gabbiani G, D'Andiran G, Pizzolato G, Browski A, Nicoletis C, de Launay A. Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. Eur J Clin Invest. 1980;10:9–16. doi: 10.1111/j.1365-2362.1980.tb00003.x. [DOI] [PubMed] [Google Scholar]
  • 26.Benson LS, Williams CS, Kahle M. Dupuytren's contracture. J Am Acad Orthop Surg. 1998;6:24–35. doi: 10.5435/00124635-199801000-00003. [DOI] [PubMed] [Google Scholar]
  • 27.Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype. Exp Cell Res. 1999;248:634–42. doi: 10.1006/excr.1999.4466. [DOI] [PubMed] [Google Scholar]
  • 28.Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, van Dijke P, Gressner AM. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125:178–91. doi: 10.1016/s0016-5085(03)00666-8. [DOI] [PubMed] [Google Scholar]
  • 29.Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci. 2002;7:d793–807. doi: 10.2741/A812. [DOI] [PubMed] [Google Scholar]
  • 30.Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin- induced lung fibrosis in mice. J Clin Invest. 1999;104:5–11. doi: 10.1172/JCI6094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhao J, Shi W, Chen H, Warburton D. Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis. J Biol Chem. 2000;275:23992–7. doi: 10.1074/jbc.M002433200. [DOI] [PubMed] [Google Scholar]
  • 32.Terada Y, Hanada S, Nakao A, Kuwahara M, Sasaki S, Marumo F. Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int. 2002;61(Suppl 1):94–8. doi: 10.1046/j.1523-1755.2002.0610s1094.x. [DOI] [PubMed] [Google Scholar]
  • 33.Kopp J, Preis E, Said H, Hafemann B, Wickert L, Gressner AM, Pallua N, Dooley S. Abrogation of Transforming Growth Factor-β signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem. 2005;280:21570–6. doi: 10.1074/jbc.M502071200. [DOI] [PubMed] [Google Scholar]
  • 34.Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, Taerum TV, Scott PG. Transforming growth factor-β in thermally injured patients with hypertrophic scars: effects of interferon α-2b. Plast Reconstr Surg. 1998;102:1317–28. doi: 10.1097/00006534-199810000-00001. [DOI] [PubMed] [Google Scholar]
  • 35.Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-β receptor. Nature. 1994;370:341–7. doi: 10.1038/370341a0. [DOI] [PubMed] [Google Scholar]
  • 36.Heldin CH, Miyazono K, van Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–71. doi: 10.1038/37284. [DOI] [PubMed] [Google Scholar]
  • 37.Massague J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753–91. doi: 10.1146/annurev.biochem.67.1.753. [DOI] [PubMed] [Google Scholar]
  • 38.Mastruzzo C, Crimi N, van Cheri C. Role of oxidative stress in pulmonary fibrosis. Monaldi Arch Chest Dis. 2002;57:173–6. [PubMed] [Google Scholar]
  • 39.Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 2000;21:49–98. doi: 10.1016/s0098-2997(00)00004-2. [DOI] [PubMed] [Google Scholar]
  • 40.Yu L, Border WA, Huang Y, Noble NA. TGF-β isoforms in renal fibrogenesis. Kidney Int. 2003;64:844–56. doi: 10.1046/j.1523-1755.2003.00162.x. [DOI] [PubMed] [Google Scholar]
  • 41.Cocco T, Sgobbo P, Clemente M, Lopriore B, Grattagliano I, Von Paola M, Villani G. Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic Biol Med. 2005;38:796–805. doi: 10.1016/j.freeradbiomed.2004.11.034. [DOI] [PubMed] [Google Scholar]
  • 42.Von Zglinicki T. Replicative senescence and the art of counting. Exp Gerontol. 2003;38:1259–64. doi: 10.1016/j.exger.2003.09.015. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES